Navigation Links
Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
Date:5/18/2009

SAN FRANCISCO, May 18 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced new findings on INTUNIV (guanfacine) extended release, a selective alpha-2A-agonist, at a major psychiatric meeting. This randomized placebo controlled trial met its primary objective, which was to evaluate the effects of INTUNIV on oppositional symptoms in children aged 6 to 12 years with a diagnosis of ADHD and the presence of oppositional symptoms. The data presented today on this investigational compound reviewed secondary efficacy measures from three different rating scales.

"A significant number of pediatric ADHD patients present with behaviors such as anger, resentfulness, defiance, and arguing with adults. It can be complicated for physicians and caregivers to find the right medication to control symptoms for children with ADHD exhibiting these behaviors," said Daniel Connor, MD, professor and division chief of child and adolescent psychiatry at the University of Connecticut Medical School. "When considered with the primary efficacy results of the current study, these data provide additional support for the clinical efficacy of INTUNIV for treating ADHD in this patient population."

On January 26, 2009, Shire filed a resubmission to the US Food and Drug Administration (FDA) of the New Drug Application to support approval for the treatment of ADHD in children and adolescents. Once available, INTUNIV will be the first selective alpha-2A receptor agonist approved for the treatment of ADHD.

INTUNIV Demonstrated Significant Efficacy in Secondary Endpoints

In this randomized, placebo-controlled, flexible-dose study, INTUNIV demonstrated significant ADHD symptom improvement in patients with oppositional symptoms as measured by the
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
2. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
3. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
6. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
7. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
8. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
9. Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
10. DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms
11. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2015 on Thursday, April 30, 2015, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
(Date:4/23/2015)... 2015 Surna, Inc. (OTCQB: SRNA), a technology ... equipment and systems for controlled environment agriculture ("CEA") ... will host a shareholder conference call to discuss ... 4:15 PM Eastern Standard Time/1:15 PM Pacific Standard ... be listen-in only, but will include a Q&A ...
(Date:4/23/2015)... -- WellStar Health System continues to raise the level ... most advanced technology. WellStar Kennestone Hospital is one of ... offer TomoTherapy and one of only two in ... TomoTherapy and CyberKnife, another leading cancer treatment. ... patient, which allows radiation to be delivered from every ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3WellStar's New, Highly Targeted Therapy Shortens Cancer Treatment Time 2
... Inc. (NASDAQ: NBIX ) today announced its financial ... first quarter of 2012, the Company reported net loss of ... net income of $2.9 million, or $0.05 income per share, ... in operating results is primarily due to the Company,s VMAT2 ...
... Reportlinker.com announces that a new ... its catalogue:   ... 2018 - Advanced Injection Devices for ... Ease of Use for Patients ...
Cached Medicine Technology:Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 2Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 3Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 4Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 5Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 6Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 7Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 8Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 9Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 10Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients 11
(Date:4/26/2015)... In an article published last month in ... biomechanics occurring during the use of handheld electronic devices such ... that use of a tablet increases mechanical demand on neck ... more than when the neck is in a neutral position. ... pointing out the potential hazards of overuse of mobile technology ...
(Date:4/25/2015)... 26, 2015 Diversified Communications has ... healthcare event. The Integrative Healthcare Symposium Canada, as ... 2015 at the Sheraton Parkway Toronto North in ... one of the most anticipated events of the ... CME program. The event aims to gather multi-disciplined ...
(Date:4/25/2015)... New York, New York (PRWEB) April 25, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) established for vaginal mesh lawsuits filed ... in the U.S. District Court, Southern District of ... April 9th, a Scheduling Conference was convened that ... the Plaintiffs’ Master Long Form Complaint. The Order ...
(Date:4/25/2015)... Illinois (PRWEB) April 25, 2015 ... enrichment and wellness, management and operations, and sales ... Meeting and Exhibition scheduled to be held from ... , LeadingAge Illinois is the largest eldercare association ... providers of services for older adults, including senior ...
(Date:4/25/2015)... Minneapolis, Minnesota (PRWEB) April 25, 2015 For ... as the premier income protection education event in the nation! ... up with The Plus Group, US to take DI Day ... Day. , George G. Davidson, CLU, ChFC, RHU, DIA, CLTC, ... Twin Cities DI Day reflects on the change by stating, ...
Breaking Medicine News(10 mins):Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Secura Consultants Takes DI Day On The Road 2
... Designing a Randomized Controlled Trial for Physical Activity, Weight ... rationale and a possible design for randomized controlled trials ... control on breast cancer risk. , There are substantial ... a healthy weight are associated with a reduction in ...
... Living, Inc. (NYSE: SRZ ) today announced ... Bank Credit Facility, which eliminates all financial covenants, except ... maturity date."We are very pleased that our bank group ... its maturity date," said Mark Ordan, Sunrise,s chief executive ...
... new findings a ,crack in the facade, of the ... abnormal mutations of two common genes can raise the ... new studies highlighting the complex genetic roots of the ... frontal lobe region, responsible for complex social behavior and ...
... Pa., April 28 In the wake of media reports ... health and safety services company, is offering advice to travelers ... what steps to take.Over one million American businesspeople, expatriates, students ... travelers, HTH Worldwide offers five basic tips:, ...
... State today issued an alert recommending that American citizens ... due to a recent outbreak of Swine Flu. While ... evolve, InsureMyTrip.com is reminding travelers of the ... http://www.newscom.com/cgi-bin/prnh/20070529/NETU076LOGO )"Right ...
... LegislatureBEDFORD, Mass., April 28 Insulet Corporation employee, ... diabetes keep him from sailing on a world-class level. ... Center for the Blind in Newton, MA won the ... Blind Sailing World Championship Regatta in New Zealand. Wallenstein, ...
Cached Medicine News:Health News:JNCI April 28 tip sheet 2Health News:JNCI April 28 tip sheet 3Health News:JNCI April 28 tip sheet 4Health News:Sunrise Signs Twelfth Amendment to Bank Credit Facility through December 2, 2009 2Health News:Sunrise Signs Twelfth Amendment to Bank Credit Facility through December 2, 2009 3Health News:Sunrise Signs Twelfth Amendment to Bank Credit Facility through December 2, 2009 4Health News:Research Highlights Genetic Risk for Autism 2Health News:Research Highlights Genetic Risk for Autism 3Health News:Research Highlights Genetic Risk for Autism 4Health News:Combating Swine Flu: HTH Worldwide Offers Tips to Travelers 2Health News:Combating Swine Flu: HTH Worldwide Offers Tips to Travelers 3Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 2Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 3Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 4Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 5Health News:InsureMyTrip.com Informs Travelers of Insurance Companies Response to Swine Flu 6Health News:Insulet Applauds Employee for Bronze Medal Performance in World Blind Sailing Championships 2
... The BF-XP40 is a scope designed specifically ... bronchi, and is also suitable for pediatric ... distal end measure a mere 2.8mm across. ... bronchi can be accomplished with greater ease. ...
... Double lumen tubes ... ventilation., ,Each ... is packaged with ... adaptors, suction catheters ...
... for endobronchial blockade of ... lung for procedures which ... set consists of an ... an Arndt Multiport Airway ...
... establish emergency airway access through the cricothyroid membrane ... gauge x 3" Angiocath I.V. catheter, which is ... stopcock to ventilate. Designed to be used with ... with a flowmeter. Similar to the Cook Emergency ...
Medicine Products: